LeMaitre Vascular Company Profile (NASDAQ:LMAT)

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:LMAT
  • CUSIP: N/A
  • Web: www.lemaitre.com
  • Market Cap: $534.18 million
  • Outstanding Shares: 18,809,000
Average Prices:
  • 50 Day Moving Avg: $29.51
  • 200 Day Moving Avg: $26.63
  • 52 Week Range: $15.87 - $33.22
  • Trailing P/E Ratio: 48.25
  • Foreward P/E Ratio: 35.06
  • P/E Growth: 2.78
Sales & Book Value:
  • Annual Revenue: $93.03 million
  • Price / Sales: 5.74
  • Book Value: $4.90 per share
  • Price / Book: 5.80
  • Annual Dividend: $0.22
  • Dividend Yield: 0.8%
  • EBIDTA: $21.22 million
  • Net Margins: 12.52%
  • Return on Equity: 13.36%
  • Return on Assets: 11.49%
  • Current Ratio: 5.81%
  • Quick Ratio: 3.89%
  • Average Volume: 209,165 shs.
  • Beta: 0.63
  • Short Ratio: 3.51
Frequently Asked Questions for LeMaitre Vascular (NASDAQ:LMAT)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Friday, April 28th. Investors of record on Wednesday, May 24th will be given a dividend of $0.055 per share on Thursday, June 8th. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Monday, May 22nd. View LeMaitre Vascular's Dividend History.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its quarterly earnings data on Wednesday, October, 26th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.15 by $0.02. The company earned $19 million during the quarter, compared to the consensus estimate of $22.20 million. LeMaitre Vascular had a net margin of 12.52% and a return on equity of 13.36%. The company's revenue for the quarter was up 22.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 EPS. View LeMaitre Vascular's Earnings History.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?

8 analysts have issued twelve-month price objectives for LeMaitre Vascular's shares. Their forecasts range from $20.00 to $31.00. On average, they expect LeMaitre Vascular's share price to reach $25.71 in the next twelve months. View Analyst Ratings for LeMaitre Vascular.

What are analysts saying about LeMaitre Vascular stock?

Here are some recent quotes from research analysts about LeMaitre Vascular stock:

  • 1. According to Zacks Investment Research, "LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (7/4/2017)
  • 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

  • George W. LeMaitre, Chairman of the Board, Chief Executive Officer
  • David B. Roberts, President, Director
  • Joseph P. Pellegrino Jr., Chief Financial Officer, Director
  • Peter R. Gebauer, President - International Operations
  • Trent G. Kamke, Senior Vice President - Operations
  • Cornelia W. LeMaitre, Vice President - Human Resources
  • Lawrence J. Jasinski, Independent Director
  • John J. O'Connor, Independent Director
  • John A. Roush, Independent Director
  • Michael H. Thomas, Independent Director

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by a number of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.00%), Thomson Horstmann & Bryant Inc. (1.95%), Summit Creek Advisors LLC (1.07%), Russell Investments Group Ltd. (0.84%), Perkins Capital Management Inc. (0.45%) and Congress Asset Management Co. MA (0.18%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?

LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Summit Creek Advisors LLC, Strs Ohio, First Quadrant L P CA and Bank of Montreal Can. Company insiders that have sold LeMaitre Vascular stock in the last year include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Concorde Asset Management LLC, Great West Life Assurance Co. Can, Eqis Capital Management Inc., Russell Investments Group Ltd., Capstone Asset Management Co., Thomson Horstmann & Bryant Inc. and Congress Asset Management Co. MA. View Insider Buying and Selling for LeMaitre Vascular.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LeMaitre Vascular stock can currently be purchased for approximately $28.40.

MarketBeat Community Rating for LeMaitre Vascular (NASDAQ LMAT)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $25.71 (9.46% downside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/10/2017Canaccord GenuityDowngradeBuy -> Hold$28.00HighView Rating Details
7/10/2017Benchmark Co.DowngradeBuy -> HoldHighView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
4/28/2017Stifel NicolausBoost Price TargetBuy$25.00 -> $29.00LowView Rating Details
3/21/2017First AnalysisInitiated CoverageOverweight -> Overweight$29.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00N/AView Rating Details
(Data available from 7/27/2015 forward)


Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Earnings History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017$0.13$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
2017 EPS Consensus Estimate: $0.67
2018 EPS Consensus Estimate: $0.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.13$0.14$0.13
Q2 20173$0.17$0.17$0.17
Q3 20173$0.17$0.18$0.17
Q4 20173$0.18$0.20$0.19
Q1 20181$0.19$0.19$0.19
Q2 20181$0.20$0.20$0.20
Q3 20181$0.20$0.20$0.20
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)


Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)
Most Recent Dividend:6/8/2017
Annual Dividend:$0.22
Dividend Yield:0.77%
Payout Ratio:36.67% (Trailing 12 Months of Earnings)
31.43% (Based on This Year's Estimates)
27.16% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Dividend History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for LeMaitre Vascular (NASDAQ:LMAT)
Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 66.45%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.32View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.40View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.75View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.47View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.56View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.39View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.24View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.60View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.70View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.00View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.00View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.00View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.00View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LeMaitre Vascular (NASDAQ:LMAT)
Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : July 24, 2017
finance.yahoo.com - July 25 at 2:54 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 18 at 10:34 PM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 6:01 AM
finance.yahoo.com logoLeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017
finance.yahoo.com - July 14 at 6:10 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : July 11, 2017
finance.yahoo.com - July 12 at 2:22 AM
rttnews.com logoLeMaitre Vascular Inc. (LMAT) Is Under Pressure In Early Trade
www.rttnews.com - July 11 at 5:23 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Cut to Hold at Canaccord Genuity
www.americanbankingnews.com - July 10 at 8:38 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Rating Lowered by Benchmark Co.
www.americanbankingnews.com - July 10 at 7:50 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Expected to Post Quarterly Sales of $25.38 Million
www.americanbankingnews.com - July 8 at 10:30 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Expected to Announce Earnings of $0.17 Per Share
www.americanbankingnews.com - July 6 at 7:35 AM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : July 3, 2017
finance.yahoo.com - July 3 at 7:55 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : June 26, 2017
finance.yahoo.com - June 27 at 12:05 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 23 at 8:46 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017
finance.yahoo.com - June 19 at 5:22 PM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 7:21 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : June 15, 2017
finance.yahoo.com - June 16 at 7:21 AM
americanbankingnews.com logo$25.38 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - June 14 at 1:42 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : June 14, 2017
finance.yahoo.com - June 14 at 10:24 AM
americanbankingnews.com logoZacks: Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) to Post $0.17 Earnings Per Share
www.americanbankingnews.com - June 12 at 8:38 AM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Earns Hold Rating from Analysts at Craig Hallum
www.americanbankingnews.com - June 6 at 9:18 AM
americanbankingnews.com logoMichael T. Wijas Sells 2,346 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - June 2 at 8:42 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 29 at 9:07 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Insider Trent G. Kamke Sells 15,780 Shares
www.americanbankingnews.com - May 26 at 7:40 PM
nasdaq.com logoLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 22, 2017 - Nasdaq
www.nasdaq.com - May 20 at 12:02 AM
americanbankingnews.com logoGeorge W. Lemaitre Sells 21,225 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - May 19 at 7:36 AM
americanbankingnews.com logo$25.38 Million in Sales Expected for LeMaitre Vascular Inc (LMAT) This Quarter
www.americanbankingnews.com - May 17 at 9:46 AM
americanbankingnews.com logo$0.17 Earnings Per Share Expected for LeMaitre Vascular Inc (LMAT) This Quarter
www.americanbankingnews.com - May 15 at 6:22 PM
finance.yahoo.com logoTime to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential
finance.yahoo.com - May 15 at 10:37 AM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Insider David B. Roberts Sells 39,531 Shares
www.americanbankingnews.com - May 12 at 7:21 PM
finance.yahoo.com logoLeMaitre Vascular to Present at Upcoming Investor Conferences
finance.yahoo.com - May 11 at 6:48 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) CEO George W. Lemaitre Sells 9,102 Shares
www.americanbankingnews.com - May 10 at 11:26 PM
americanbankingnews.com logoGeorge W. Lemaitre Sells 34,517 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - May 10 at 10:44 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Chairman George W. Lemaitre Sells 63,622 Shares
www.americanbankingnews.com - May 10 at 10:44 PM
finance.yahoo.com logoCan The Uptrend Continue for LeMaitre Vascular (LMAT)?
finance.yahoo.com - May 9 at 11:58 AM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Insider David B. Roberts Sells 44,340 Shares
www.americanbankingnews.com - May 5 at 8:02 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Chairman George W. Lemaitre Sells 87,342 Shares
www.americanbankingnews.com - May 5 at 8:10 AM
americanbankingnews.com logoLeMaitre Vascular (LMAT) Earning Favorable Press Coverage, Report Shows
www.americanbankingnews.com - May 4 at 1:22 AM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 2 at 10:52 PM
americanbankingnews.com logoQ2 2017 EPS Estimates for LeMaitre Vascular Inc Increased by First Analysis (LMAT)
www.americanbankingnews.com - May 2 at 8:36 AM
americanbankingnews.com logoBarrington Research Analysts Increase Earnings Estimates for LeMaitre Vascular Inc (LMAT)
www.americanbankingnews.com - May 1 at 9:50 AM
americanbankingnews.com logoLeMaitre Vascular (LMAT) Receiving Somewhat Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 30 at 5:20 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Given "Buy" Rating at Stifel Nicolaus
www.americanbankingnews.com - April 29 at 12:46 PM
americanbankingnews.com logoLeMaitre Vascular Inc (LMAT) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 29 at 9:26 AM
americanbankingnews.com logoFY2018 EPS Estimates for LeMaitre Vascular Inc (LMAT) Boosted by Analyst
www.americanbankingnews.com - April 28 at 11:33 PM
americanbankingnews.com logoLeMaitre Vascular Inc Plans Quarterly Dividend of $0.06 (LMAT)
www.americanbankingnews.com - April 28 at 10:46 PM
finance.yahoo.com logoLeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals
finance.yahoo.com - April 28 at 7:13 PM
zacks.com logoTop Ranked Momentum Stocks to Buy for April 28th
www.zacks.com - April 28 at 9:32 AM
rttnews.com logoCompany Spotlight: LeMaitre
www.rttnews.com - April 28 at 9:32 AM
americanbankingnews.com logoLeMaitre Vascular's (LMAT) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - April 27 at 10:44 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Very Likely to Affect LeMaitre Vascular (LMAT) Share Price
www.americanbankingnews.com - April 27 at 8:24 PM



LeMaitre Vascular (LMAT) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff